Researchers from the team 1 (Tumor and vascular biology laboratory), in collaboration with researchers from the IBGC (CNRS / Université de Bordeaux) have published their work in the prestigious journal EMBO Molecular Medicine. This work highlights the potential of mubritinib to target a metabolic vulnerability...

Aksam Merched, a professor with the Mircade team at BRIC, led by Christophe Grosset, has secured major funding of €600,000 from the National Cancer Institute (INCa). He is one of just four winners selected under the call for projects aimed at “supporting particularly innovative initiatives...

2024 was the year of our unit's first mid-term review, with a visit from our Scientific Board, comprising René Bernards (NKI - Netherlands), Jean Ehrland Ricci (CMMM, Nice - France), Urzula Hibner (IGMM, Montpellier - France), Ruth Scherz-Shouval (Weizmann Institute of Science, Rehovot - Israel)...

On the occasion of the official presentation of funding by the ARC Foundation for cancer research for the “CLASSE” project led by Pierre-Louis Soubeyran (team 11 cancer and age) on December 5, some thirty ARC Foundation donors came to meet scientists in our laboratories. After a...